STC3141

DB16475InvestigationalSmall molecule

STC3141, was investigated in clinical trial NCT04880694 to evaluate its safety and effect in subjects with severe COVID-19 pneumonia.

Mechanism: STC3141 is used in the treatment of sepsis. The specific mechanism of action behind the drug is currently unknown.
Curator reviewed
Code names: STC3141

Resolves to

Targets

What you can answer from here — as of July 08, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with STC3141, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.